Santhera publiziert Zeitplan für die Aktienzusammenlegung NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...
Shareholders Approve all Board Proposals at Today’s Annual General Meeting Pratteln, Switzerland, June 27, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders approved...
Santhera vergibt exklusive Nordamerika-Lizenz für Vamorolone an Catalyst Pharmaceuticals in einer Transaktion im Wert von bis zu USD 231 Millionen zuzüglich Lizenzgebühren Ad-hoc-Mitteilung...
Santhera Publishes Agenda for its Annual General Meeting NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO...
Santhera veröffentlicht Jahresbericht 2022 Ad-hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 31. Mai 2023 – Santhera Pharmaceuticals (SIX: SANN) gibt die Veröffentlichung des...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 190.2 | 190.2 | 190.2 | 2218 | 190.2 | DE |
4 | 0 | 0 | 190.2 | 190.2 | 190.2 | 1535 | 190.2 | DE |
12 | 0 | 0 | 190.2 | 190.2 | 190.2 | 852 | 190.2 | DE |
26 | 0 | 0 | 190.2 | 190.2 | 190.2 | 499 | 190.2 | DE |
52 | 0 | 0 | 190.2 | 190.2 | 190.2 | 451 | 190.2 | DE |
156 | 0 | 0 | 190.2 | 190.2 | 190.2 | 1867 | 190.2 | DE |
260 | 0 | 0 | 190.2 | 190.2 | 190.2 | 1753 | 190.2 | DE |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관